Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPmyCOPD
NCT07460154Recruiting
- Sponsor
- Northumbria Healthcare NHS Foundation Trust
- Start
- Mar 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic obstructive pulmonary disease (COPD), sponsored by Northumbria Healthcare NHS Foundation Trust. Primary endpoint: Cumulative dose of oral prednisolone over 12-months. Started Mar 2026; status: recruiting.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07460154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07460154.